FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel cyclic compounds of general formula which possess properties of CaSR modulator. In general formula I group
represents cycloalkyl, which contains 4-7 carbon atoms, optionally substituted with one or several similar or different substituents, selected from R2, R3, R4 or R5; A represents 1-naphthyl; R1 represents methyl, ethyl or n-propyl, each of which is optionally substituted with one or several, similar or different substituents, selected from halogen and hydroxy; R2 and R3 represent hydrogen; R4 represents hydrogen, halogen, hydroxy or C1-6alkyl; each R5 represents independently one or several similar or different substituents, represented by hydrogen or C1-6alkyl; G represents -C(O)NH2, C3-8cycloalkyl, C1-6heterocycloalkyl, C1-6heterocycloalkenyl, C3-8cycloalkenyl, C6-14aryl, C1-10heteroaryl, C6-10arylamino, hydroxyaminocarbonyl, C6-10arylaminocarbonyl, C1-4aminocarbonyl, C1-6heterocycloalkylcarbonyl, C1-10heteroarylaminocarbonyl, C6-10arylsulfonylaminocarbonyl, C6-14aryloxy, or C1-4alkoxycarbonyl, where said substituents are optionally additionally substituted with one or several, similar or different substituents. Other values of radicals are given in the formula of invention.
EFFECT: compounds can be applied in treatment, relief or prevention of physiological disorders or diseases, associated with impairment of activity of CaSR, such as hyperparathyreosis, and other diseases.
23 cl, 9 dwg, 3 tbl, 315 ex
Title | Year | Author | Number |
---|---|---|---|
3-CARBONYLAMINO-5-CYCLOPENTYL-1H-PYRAZOLE COMPOUNDS WITH CDK2 INHIBITOR ACTIVITY | 2020 |
|
RU2797889C2 |
CYCLOALKANE-1,3-DIAMINE DERIVATIVE | 2019 |
|
RU2793247C2 |
GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
IMPROVED APELIN RECEPTOR AGONISTS (APJ) AND THEIR USE | 2016 |
|
RU2766148C1 |
ANTIPROLIFERATIVE AGENTS FOR THE TREATMENT OF PAH | 2020 |
|
RU2786588C1 |
UREA DERIVATIVES AND THERAPEUTIC USE THEREOF IN TREATING, AMONG OTHER THINGS, RESPIRATORY TRACT DISEASES | 2011 |
|
RU2586223C2 |
3-CARBOXYPROPYL-AMINOTETRALINE DERIVATIVES AND RELATED COMPOUNDS AS MU-OPIOID RECEPTOR ANTAGONISTS | 2008 |
|
RU2482107C2 |
INDOLE COMPOUNDS AS CELL NECROSIS INHIBITORS | 2008 |
|
RU2477282C2 |
INDOLE AND INDAZOLE DERIVATIVES SHOWING PRESERVING ACTION ON CELLS, TISSUES AND ORGANS | 2009 |
|
RU2460525C2 |
SUBSTITUTED METHYLPHENYL KETONES SUITABLE FOR USE AS PDE4 INHIBITORS | 2007 |
|
RU2493149C2 |
Authors
Dates
2014-08-10—Published
2008-11-20—Filed